Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Return on Sales (2025)

Historic Return on Sales for Coeptis Therapeutics Holdings (COEP) over the last 1 years, with Q3 2025 value amounting to 12.21%.

  • Coeptis Therapeutics Holdings' Return on Sales changed N/A to 12.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 27.28%, marking a year-over-year change of. This contributed to the annual value of 179.32% for FY2021, which is N/A changed from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported Return on Sales of 12.21% as of Q3 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Return on Sales registered a high of 12.21% during Q3 2025, and its lowest value of 54.41% during Q1 2025.